 |
인쇄하기
취소
|
KFDA to introduce fast review system for BT products next year
The Korea Food and Drug Administration unveiled its plan to implement a fast review system from next year to shorten the screening period of biopharmaceutical products' safety and efficacy data from 14 months to 6 months.
The health regulator also plans to introduce another GMP standard for the manufacture of research-related biological products, making it easier to monitor the research prog...
The health regulator also plans to introduce another GMP standard for the manufacture of research-related biological products, making it easier to monitor the research prog...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.